Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience

被引：0
|
作者：
Εvangelos Cholongitas
Ioannis Goulis
Eleni Theocharidou
Nikolaos Antoniadis
Ioannis Fouzas
Dimitrios Giakoustidis
George Imvrios
Olga Giouleme
Vasilios Papanikolaou
Evangelos Akriviadis
Themistoklis Vasiliadis
机构：
[1] Medical School of Aristotle University,4th Department of Internal Medicine, Hippokration General Hospital of Thessaloniki
[2] Medical School of Aristotle University,2nd Propedeutic Department of Internal Medicine, Hippokration Hospital
[3] Aristotle University of Thessaloniki,Department of Transplant Surgery
[4] Aristotle University of Thessaloniki,1st Propedeutic Department of Internal Medicine, AHEPA General Hospital
来源：
Hepatology International | 2014年 / 8卷
关键词：
Everolimus; Liver transplantation; Mammalian target of rapamycin inhibitor; Renal function; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：137 / 145
页数：8
相关论文
共 50 条
  • [21] CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN MAINTENANCE LIVER TRANSPLANT PATIENTS: RESULTS FROM 94 PATIENTS
    Vallin, M.
    Guillaud, O.
    Morard, I.
    Gagnieu, M-C
    Mentha, G.
    Adham, M.
    Morelon, E.
    Giostra, E.
    Boillot, O.
    Dumortier, J.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S186 - S186
  • [22] CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN MAINTENANCE LIVER TRANSPLANT PATIENTS: RESULTS FROM 94 PATIENTS
    Vallin, Melanie
    Guillaud, Olivier
    Morard, Isabelle
    Gagnieu, Marie-Claude
    Mentha, Gilles
    Adham, Mustapha
    Morelon, Emmanuel
    Giostra, Emile
    Boillot, Olivier
    Dumortier, Jerome
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 120 - 120
  • [23] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Saliba, F.
    Metselaar, H. J.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
  • [24] THE CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS AMELIORATES RENAL FUNCTION AND PREVENTS HEPATOCELLULAR CARCINOMA WITHOUT ANY EPISODE OF REJECTION
    Cholongitas, E.
    Theocharidou, E.
    Antoniadis, N.
    Goulis, J.
    Fouzas, J.
    Imvrios, G.
    Giouleme, O.
    Akriviadis, E.
    Papanikolaou, V.
    Vasiliadis, T.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S65 - S65
  • [25] Pregnancy under everolimus-based immunosuppression
    Veroux, Massimiliano
    Corona, Daniela
    Veroux, Pierfrancesco
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 (12) : E115 - E117
  • [26] Efficacy and Safety of Everolimus in Liver Transplant Recipients - A Single Center Experience
    Brasil, Ivelise R. C.
    Esmeraldo, Ronaldo M.
    Esmeraldo, Romero M.
    Guimaraes, Vicente B. F.
    de Paula, Francisco T. M.
    Lucena, Israelly E. G.
    Freitas, Daniel B. P.
    [J]. LIVER TRANSPLANTATION, 2014, 20 : S171 - S171
  • [27] Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency
    Wujcik, K.
    Barkoff, L.
    Lee, J.
    Hollander, S. A.
    Chen, C.
    Gonzales, S.
    Profita, E.
    Almond, C.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S623 - S624
  • [28] Increased Risk of Venous Thromboembolism With Everolimus-Based Immunosuppression in Lung Transplant Recipients: A Case-Controlled Study
    Schoeppler, K.
    Lyu, D.
    Grazia, T.
    Crossno, J., Jr.
    Vandervest, K.
    Zamora, M.
    [J]. TRANSPLANTATION, 2014, 98 : 804 - 805
  • [29] Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney Transplant
    Malvezzi, Paolo
    Jouve, Thomas
    Rostaing, Lionel
    [J]. Experimental and Clinical Transplantation, 2016, 14 (04) : 361 - 366
  • [30] Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections
    Fuehner, Thomas
    Dierich, Martin
    Duesberg, Christoph
    DeWall, Claudia
    Welte, Tobias
    Haverich, Axel
    Warnecke, Gregor
    Simon, Andre R.
    Gottlieb, Jens
    [J]. ANTIVIRAL THERAPY, 2011, 16 (05) : 733 - 740
12345